Immunity for Health: Vaccines & Immunotherapy

16–17 Oct 2024 | RodeBol Events

Thomas Van Doninck

Project manager / Scientist

ImmuneSpec

Niel, Belgium

2 profile visits

As a project manager at ImmuneSpec, I lead immunopeptidomics projects and optimize processes to identifiy targets for immunotherapy and prophylactic vaccines.

About me

My organisation

ImmuneSpec is a biotech service provider that offers high-sensitive immunopeptidomics/MAPPS/ligandomics analysis as a service. With our analysis we can identify maximized numbers of MHC I and MHC II associated peptides like neoantigens, tumor associated antigens (for development of immunotherapeutics & PM) but also pathogen derived antigens (for development of prophylactic vaccines) from biological samples. In the context of immunogenicity risk assessment we can decipher potential T cell epitopes from biotherapeutics for the selection of safe, high efficacy biotherapeutics.

Skills

  • Mass Spectrometry
  • Immunoaffinity purification
  • immunopeptidomics

Interests

  • Prophylactic vaccines
  • Neoantigens
  • immunotherapy
  • personalised medicine
  • immunopeptidomics

Additional questions

How would you categorise yourself?

Service providerProject manager

Organisation Type

Biotech company/R&DContract Research Organizations (CRO)

Areas of expertise

Personalised medicineResearch and developmentPreclinical research Immunotherapy R&DVaccine R&DImmuno-oncology

Therapeutic areas

Infectious diseases OncologyImmunologyAutoimmune disorders

1. I accept the General Terms & Conditions and Privacy Statement, available on flandersvaccine.be and agree that pictures can be taken at the event and be used for Flanders Vaccine communication purposes.

I agree